v3.24.1.1.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Mar. 25, 2022
Cash flows from operating activities:      
Net income $ 152,888 $ 187,494 $ 119,555
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 71,382 50,808 48,527
Amortization of deferred financing costs 527 99 101
Deferred income taxes (18,613) (40,116) 7,498
Stock-based compensation 42,457 61,798 33,548
Loss (gain) on disposal of assets 70 285 (349)
Change in fair value of contingent consideration 0 (2,800) (2,000)
Impairment of long-lived assets 13,218 0 0
Provisions for inventory and expected credit losses 10,286 (1,438) 6,297
Change in fair value of marketable securities 3,579 (7,471) (3,722)
Changes in operating assets and liabilities:      
Trade accounts receivable (7,964) (12,484) (18,347)
Accounts receivable - other (1,035) 2,226 (2,668)
Inventories (15,848) (75,150) (4,471)
Prepaid expenses and other assets (40,231) (23,263) (19,450)
Trade accounts payable (12,653) 11,958 (4,348)
Due to (from) related party 5,231 18,326 (659)
Accrued expenses and other current and long-term liabilities (21,579) 22,934 (3,383)
Net cash provided by operating activities 181,715 193,206 156,129
Cash flows from investing activities:      
Purchases of property, plant and equipment (124,772) (79,775) (69,941)
Acquisition of business, net of cash acquired (408,119) (19,921) (14,549)
Proceeds from sales of property, plant and equipment 0 0 27,408
Sales (purchases) in marketable securities 16,175 0 (9,189)
Net cash used in investing activities (516,716) (99,696) (66,271)
Cash flows from financing activities:      
Loans made to related party 0 (7,500) (7,500)
Borrowings of 2023 Term Loan Facility, net of deferred financing costs 245,452 0 0
Repayments of other debt (842) 0 0
Finance lease payments (142)    
Receipts on related party notes receivable 3,750 2,812 0
Payments for taxes related to net share settlement of equity awards (25,900) (18,061) (638)
Proceeds from issuance of common stock under equity award and employee purchase plan awards 3,635 2,793 2,831
Dividends paid to non-controlling interest 0 (42) 0
Payments of debt issuance costs (1,450) 0 0
Net cash provided by (used in) financing activities 198,878 (19,998) (5,307)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (421) (4,606) 1,373
Net (decrease) increase in cash and cash equivalents and restricted cash (136,544) 68,906 85,924
Cash and cash equivalents and restricted cash at beginning of period 358,705 289,799 203,875
Cash and cash equivalents and restricted cash at end of period: 222,161 358,705 289,799
Reconciliation of cash and cash equivalents and restricted cash:      
Cash and cash equivalents at beginning of period 351,576 282,383 197,214
Restricted cash at beginning of period 7,129 7,416 6,661
Cash and cash equivalents at end of period 212,143 351,576 282,383
Restricted cash at end of period 10,018 7,129 7,416
Supplemental disclosures of cash flow information:      
Cash paid for interest 10,153 1,923 813
Cash paid for income taxes, net of refunds 89,927 58,209 22,195
Non-cash transactions:      
Property, plant and equipment purchases included in trade accounts payable and accrued expenses (4,157) (16,369) (2,021)
Right-of-use assets obtained in exchange for lease liabilities 10,450 4,870 3,159
2020 Term Loan Facility      
Cash flows from financing activities:      
Repayment of Term Loan Facility (25,000) 0 0
2023 Term Loan Facility      
Cash flows from financing activities:      
Repayment of Term Loan Facility $ (625) $ 0 $ 0